CD BioGlyco Expands Analytical Capabilities with New Glycomic Characterization Service
United States, August 12, 2026 — Glycans are notoriously complex and hard to analyze—a problem that has long held back biopharmaceutical R&D. As regulators tighten their requirements, glycosylation analysis is making its way from the… Read More »CD BioGlyco Expands Analytical Capabilities with New Glycomic Characterization Service





